By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acton Pharmaceuticals, Inc. 

225 Cedar Hill Street
Suite 337
Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-624-8733 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
MEDA: Acquisition of Acton Pharmaceuticals, Inc. Completed 10/21/2013 10:05:54 AM
Meda AB (MEDA-A.ST) Snags U.S. Respiratory Company Acton Pharmaceuticals, Inc. for Up to $200 Million 8/30/2013 6:46:16 AM
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol 10/25/2011 6:57:41 AM
Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology 10/11/2011 11:05:26 AM
Acton Pharmaceuticals, Inc. Announces Additions to the Executive Management Team 5/5/2011 2:34:17 PM
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R) (flunisolide HFA, 80 mcg) Inhalation Aerosol 11/3/2010 10:16:12 AM
Acton Pharmaceuticals, Inc. Forms Scientific Advisory Board 5/24/2010 9:58:55 AM
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital 1/6/2010 7:09:22 AM
//-->